Literature DB >> 11676487

Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro.

H Xue1, A Atakilit, W Zhu, X Li, D M Ramos, R Pytela.   

Abstract

Expression of the alpha(v)beta6 integrin is strikingly upregulated in several types of carcinoma, including human oral squamous cell carcinoma (SCC). Employing a neutralizing monoclonal antibody to alpha(v)beta6, we investigated its role in cell adhesion, proliferation, migration, and in vivo growth of an invasive human SCC line, termed HSC-3. We found that alpha(v)beta6 is strictly required for HSC-3 cell growth in a three-dimensional collagen gel and also prominently contributes to cell migration in two different assay systems. In addition, the anti-alpha(v)beta6 antibody inhibited the invasive growth of HSC-3 cells transorally injected into nude mice. In the presence of the coinjected antibody, the average tumor size at 10 days was reduced by 59%. Histologically, antibody-treated tumors appeared less invasive than control tumors. Furthermore, intravenous application of a neutralizing antibody to the alpha(v) integrin subunit retarded HSC-3 tumor growth. These results point to a possible critical role of the alpha(v)beta6 integrin in controlling growth and invasion of human oral cancer cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676487     DOI: 10.1006/bbrc.2001.5813

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold.

Authors:  Lauren A Austin; Bin Kang; Chun-Wan Yen; Mostafa A El-Sayed
Journal:  Bioconjug Chem       Date:  2011-10-31       Impact factor: 4.774

2.  Plasmonic imaging of human oral cancer cell communities during programmed cell death by nuclear-targeting silver nanoparticles.

Authors:  Lauren A Austin; Bin Kang; Chun-Wan Yen; Mostafa A El-Sayed
Journal:  J Am Chem Soc       Date:  2011-10-18       Impact factor: 15.419

3.  XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles.

Authors:  Lauren A Austin; Megan A Mackey; Marwa M Afifi; Mostafa A El-Sayed
Journal:  Bioconjug Chem       Date:  2014-01-10       Impact factor: 4.774

4.  Evaluation of Two Optical Probes for Imaging the Integrin αvβ6- In Vitro and In Vivo in Tumor-Bearing Mice.

Authors:  Tanushree Ganguly; Sarah Y Tang; Nadine Bauer; Julie L Sutcliffe
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

5.  A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.

Authors:  Chao Zhang; Richard Kimura; Lotfi Abou-Elkacem; Jelena Levi; Lingyun Xu; Sanjiv Sam Gambhir
Journal:  J Nucl Med       Date:  2016-05-26       Impact factor: 10.057

6.  Introduction to metallic nanoparticles.

Authors:  Vicky V Mody; Rodney Siwale; Ajay Singh; Hardik R Mody
Journal:  J Pharm Bioallied Sci       Date:  2010-10

7.  Inducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocages.

Authors:  Megan A Mackey; Farhat Saira; Mahmoud A Mahmoud; Mostafa A El-Sayed
Journal:  Bioconjug Chem       Date:  2013-06-10       Impact factor: 4.774

8.  Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Zequn Li; Pengfei Lin; Chao Gao; Cheng Peng; Song Liu; Huijie Gao; Ben Wang; Jiayong Wang; Jun Niu; Weibo Niu
Journal:  Tumour Biol       Date:  2015-11-07

9.  Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.

Authors:  G J Thomas; I R Hart; P M Speight; J F Marshall
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

10.  Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.

Authors:  Simon L Goodman; Hans Juergen Grote; Claudia Wilm
Journal:  Biol Open       Date:  2012-02-06       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.